Cargando…

Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years

A recent summary-level meta-analysis comprising randomized, controlled trials (RCTs) of femoropopliteal paclitaxel-coated balloon and stent intervention identified excess late mortality in the paclitaxel-treated patients. METHODS: We evaluated the safety of the Stellarex drug-coated balloon (DCB) fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gray, William A., Jaff, Michael R., Parikh, Sahil A., Ansel, Gary M., Brodmann, Marianne, Krishnan, Prakash, Razavi, Mahmood K., Vermassen, Frank, Zeller, Thomas, White, Roseann, Ouriel, Kenneth, Adelman, Mark A., Lyden, Sean P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784772/ https://www.ncbi.nlm.nih.gov/pubmed/31567024 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040518

Ejemplares similares

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
por: Krishnan, Prakash, et al.
Publicado: (2017)

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
por: Schroeder, Henrik, et al.
Publicado: (2017)

Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials
por: Schneider, Peter A., et al.
Publicado: (2020)

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018)

Can Paclitaxel Coated Balloons Have a Deep Impact on Critical Limb Ischemia?
por: Parikh, Sahil A., et al.
Publicado: (2021)

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
por: Laird, John A., et al.
Publicado: (2019)

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial
por: Schneider, Peter A., et al.
Publicado: (2018)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial
por: Zeller, Thomas, et al.
Publicado: (2014)

Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study
por: Schroeder, Henrik, et al.
Publicado: (2015)

Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020)

Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020)

Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2021)

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: 12-Month Results From the IN.PACT SFA Randomized Trial
por: Tepe, Gunnar, et al.
Publicado: (2015)

Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing
por: Granada, Juan F, et al.
Publicado: (2014)

Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment
por: Brodmann, Marianne, et al.
Publicado: (2017)

Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022)

Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis
por: Reijnen, Michel M. P. J., et al.
Publicado: (2023)

Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits
por: Chowdhury, Mohammed M., et al.
Publicado: (2020)

Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study
por: Zeller, Thomas, et al.
Publicado: (2017)

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
por: Dake, Michael D., et al.
Publicado: (2019)

Paclitaxel-coated balloon dilation for central airway obstruction
por: Sakata, Kenneth K., et al.
Publicado: (2018)

Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study
por: Shammas, Nicolas W, et al.
Publicado: (2022)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2016)

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics
por: Du, Xin, et al.
Publicado: (2019)

Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters
por: Speck, Ulrich, et al.
Publicado: (2018)

Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
por: Teichgräber, Ulf
Publicado: (2020)

A case of vasculitis after paclitaxel drug-coated balloon angioplasty
por: Hawkins, Kelly, et al.
Publicado: (2022)

Mortality after Use of Paclitaxel-Coated Balloons Correlates with Total Cumulative Dosage of Paclitaxel in Real-World Analysis
por: Heo, Seon-Hee, et al.
Publicado: (2021)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
por: Turner, Emily, et al.
Publicado: (2018)

Percutaneous treatment of left main chronic total occlusion with paclitaxel-coated balloon
por: Kim, Mijin, et al.
Publicado: (2021)

The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2016)

Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2017)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis
por: Pavo, Noemi, et al.
Publicado: (2016)

Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis
por: Barry, Ian Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f87i471dun2512mbsg3k59vec5